EP2461795A2 — Sublingual and buccal film compositions
Assigned to Indivior UK Ltd · Expires 2012-06-13 · 14y expired
What this patent protects
The present invention relates to products and methods for treatment of narcotic dependence in a user. The invention more particularly relates to self- supporting dosage forms which provide an active agent for treating narcotic dependence while providing sufficient buccal adhesion…
USPTO Abstract
The present invention relates to products and methods for treatment of narcotic dependence in a user. The invention more particularly relates to self- supporting dosage forms which provide an active agent for treating narcotic dependence while providing sufficient buccal adhesion of the dosage form.
Drugs covered by this patent
- Subutex (Buprenorphine Hydrochloride) · Indivior
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.